RE: Questions to ask9 Jan 2024 18:31
Yes so many unanswered questions for Shareholders which no doubt the SL and Bondholders have the answers to.
1. Who was the potential JVP
2. Who terminated the discussions and why
3. What commercial terms were discussed/proposed if any
4. Was $1m of NGL injectant purchased in Oct/Nov as noted in the RNS
5. Was NGL injectant increased in Oct, Nov and Dec, if not why not.
6. Why was a Rights Issue or other form of Funding not done at 4p, or a higher figure, instead of a placing with Anavio which was eventually done at 2.6p
If we knew the answers to the above we could make an informed decision on whether to buy, hold or sell.